Document is current
Any future updates will be listed below
-
Authors
Sun, Hanyong
Yang, Weiqin
Tian, Yuan
Zeng, Xuezhen
Zhou, Jingying
Mok, Myth T. S.
Tang, Wenshu
Feng, Yu
Xu, Liangliang
Chan, Anthony W. H.
Tong, Joanna H. https://orcid.org/0000-0003-4042-6957
Cheung, Yue-Sun
Lai, Paul B. S.
Wang, Hector K. S.
Tsang, Shun-Wa
Chow, King-Lau
Hu, Mengying
Liu, Rihe
Huang, Leaf
Yang, Bing
Yang, Pengyuan
To, Ka-Fai
Sung, Joseph J. Y.
Wong, Grace L. H.
Wong, Vincent W. S. https://orcid.org/0000-0003-2215-9410
Cheng, Alfred S. L.
- License Information
-
More Information
Article History
Received: 3 January 2018
Accepted: 31 October 2018
First Online: 6 December 2018
Competing interests
: G.L.H.W. has served as an advisory committee member for Gilead Sciences, and as a speaker for Abbott, Abbvie, Bristol-Myers Squibb, Echosens, Furui, Gilead Sciences, Janssen and Roche. V.W.S.W. has served as an advisory board member for AbbVie, Allergan, Center for Outcomes Research in Liver Diseases, Gilead Sciences, Janssen, Perspectum Diagnostics and Pfizer; and received lecture fees from Bristol-Myers Squibb, Echosens, Gilead Sciences, and Merck. The remaining authors declare no competing interests.
